Pharmacological studies leading to the identification of hyperforin as a CNS-active component of Hypericum perforatum

被引：0

作者：

Nöldner, M ^{[1
]}

Chatterjee, SS ^{[1
]}

Erdelmeier, C ^{[1
]}

机构：

[1] Dr Willmar Schwabe GmbH & Co, Res Labs, D-76209 Karlsruhe, Germany

来源：

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

P5146

引用

页码：R495 / R495

页数：1

共 17 条

[11] QUALITATIVE AND QUANTITATIVE STUDIES ON THE PRESENCE OF CNS-ACTIVE PHENYLPROPYLAMINES IN COMMERCIAL DRUGS AND THEIR DISTRIBUTION IN DIFFERENT PARTS OF CATHA-EDULIS FORSK (CELASTRACEAE)
SCHORNO, HX
BRENNEISEN, R
STEINEGGER, E
PHARMACEUTICA ACTA HELVETIAE, 1982, 57 (5-6): : 168 - 176
[12] Main active components of St. John's Wort (Hypericum perforatum) extracts:: Current analytical procedures for pharmaco kinetics and concentration-response studies
Caccia, Silvio
CURRENT PHARMACEUTICAL ANALYSIS, 2006, 2 (01) : 59 - 68
[13] DETECTION OF PERICINE, A NEW CNS-ACTIVE INDOLE ALKALOID FROM PICRALIMA-NITIDA CELL-SUSPENSION CULTURE BY OPIATE RECEPTOR-BINDING STUDIES
ARENS, H
BORBE, HO
ULBRICH, B
STOCKIGT, J
PLANTA MEDICA, 1982, 46 (04) : 210 - 214
[14] In vitro binding studies with two Hypericum perforatum extracts -: Hyperforin, hypericin and biapigenin -: On 5-HT6, 5-HT7, GABAA/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters
Gobbi, M
Moia, M
Pirona, L
Morazzoni, P
Mennini, T
PHARMACOPSYCHIATRY, 2001, 34 : S45 - S48
[15] Identification by high-performance liquid chromatography diode array detection mass spectrometry and quantification by high-performance liquid chromatography UV absorbance detection of active constituents of Hypericum perforatum
Brolis, M
Gabetta, B
Fuzzati, N
Pace, R
Panzeri, F
Peterlongo, F
JOURNAL OF CHROMATOGRAPHY A, 1998, 825 (01) : 9 - 16
[16] Laboratory and preclinical studies on the anti-inflammatory and anti-oxidant properties of rosehip powder -: Identification and characterization of the active component GOPO®
Kharazimi, Arsalan
OSTEOARTHRITIS AND CARTILAGE, 2008, 16 : S5 - S7
[17] Studies leading to the identification of ZD1839 (Iressa™):: An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer
Barker, AJ
Gibson, KH
Grundy, W
Godfrey, AA
Barlow, JJ
Healy, MP
Woodburn, JR
Ashton, SE
Curry, BJ
Scarlett, L
Henthorn, L
Richards, L
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1911 - 1914

← 1 2 →